Thyrotropin and homologous glycoprotein hormone receptors: Structural and functional aspects of extracellular signaling mechanisms

Endocrine Reviews

Volumn 30, Issue 2, 2009, Pages 133-151

  Kleinau, Gunnar ^a   Krause, Gerd ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN RECEPTOR; CYSTEINE; FOLLITROPIN RECEPTOR; LEUCINE; LUTEINIZING HORMONE RECEPTOR; THYROTROPIN; THYROTROPIN RECEPTOR;

AMINO TERMINAL SEQUENCE; BINDING SITE; BIOINFORMATICS; CRYSTAL STRUCTURE; ENTEROCHROMAFFIN LIKE CELL; HORMONE BINDING; HUMAN; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; EXTRACELLULAR SPACE; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECEPTORS, GONADOTROPIN; RECEPTORS, THYROTROPIN; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; THYROTROPIN;

EID: 65249116958     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2008-0044     Document Type: Review

References (197)

1. Schwartz TW, Frimurer TM, Holst B, Rosenkilde MM, Elling CE 2006 Molecular mechanism of 7TM receptor activation-a global toggle switch model. Annu Rev Pharmacol Toxicol 46:481-519
2. Schoneberg T, Schulz A, Gudermann T 2002 The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. Rev Physiol Biochem Pharmacol 144:143-227
3. TaoYX 2006 Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharmacol Ther 111:949-973
4. Schoneberg T, Schulz A, Biebermann H, Hermsdorf T, Rompler H, Sangkuhl K 2004 Mutant G-protein-coupled receptors as a cause of human diseases. Pharmacol Ther 104:173-206
5. Flower DR 1999 Modelling G-protein-coupled receptors for drug design. Biochim Biophys Acta 1422:207-234
6. Kosugi S, Sugawa H, Mori T 1996 TSH receptor and LH receptor. Endocr J 43:595-604
7. Themmen APN, Huhtaniemi IT 2000 Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21:551-583
8. Ascoli M, Fanelli F, Segaloff DL 2002 The lutropin/ choriogonadotropin receptor, a 2002 perspective. Endocr Rev 23:141-174
9. Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, Dumont JE, Schultz G 1996 The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci USA 93:116-120
10. Van Sande J, Dequanter D, Lothaire P, Massart C, Dumont JE, Erneux C 2006 Thyrotropin stimulates the generation of inositol 1,4,5-trisphosphate in human thyroid cells. J Clin Endocrinol Metab 91:1099-1107
11. Kero J, Ahmed K, Wettschureck N, Tunaru S, Wintermantel T, Greiner E, Schutz G, Offermanns S 2007 Thyrocyte-specific Gq/ G11 deficiency impairs thyroid function and prevents goiter development. J Clin Invest 117:2399-2407
12. BuchTR, BiebermannH,KalwaH,PinkenburgO,HagerD,Barth H, Aktories K, Breit A, Gudermann T 2008 G13-dependent activation of MAPK by thyrotropin. J Biol Chem 283:20330-20341
13. SzkudlinskiMW,FremontV,Ronin C,Weintraub BD 2002 Thyroidstimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev 82:473-502
14. Nakabayashi K, Matsumi H, Bhalla A, Bae J, Mosselman S, Hsu SY, Hsueh AJ 2002 Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor. J Clin Invest 109:1445-1452
15. Ando T, Davies TF 2005 Monoclonal antibodies to the thyrotropin receptor. Clin Dev Immunol 12:137-143
16. Rodien P, Ho SC, Vlaeminck V, Vassart G, Costagliola S 2003 Activating mutations of TSH receptor. Ann Endocrinol (Paris) 64: 12-16
17. KleinauG,BrehmM,WiedemannU,LabuddeD,LeserU,Krause G 2007 Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. Mol Endocrinol 21:574-580
18. Van Sande J, Massart C, Costagliola S, Allgeier A, Cetani F, Vassart G, Dumont JE 1996 Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol 119:161-168
19. Chen CR, Chazenbalk GD, McLachlan SM, Rapoport B 2003 Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activity. Endocrinology 144:3821-3827
20. Jaschke H, Neumann S, Moore S, Thomas CJ, Colson AO, Costanzi S, Kleinau G, Jiang JK, Paschke R, Raaka BM, Krause G, Gershengorn MC 2006 A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR). J Biol Chem 281:9841-9844
21. Moore S, Jaeschke H, Kleinau G, Neumann S, Costanzi S, Jiang JK, Childress J, Raaka BM, Colson A, Paschke R, Krause G, Thomas CJ, Gershengorn MC 2006 Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patterns. J Med Chem 49:3888-3896
22. Zhang ML, Sugawa H, Kosugi S, Mori T 1995 Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain. Biochem Biophys Res Commun 211:205-210
23. Wonerow P, Schoneberg T, Schultz G, Gudermann T, Paschke R 1998 Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation. J Biol Chem 273:7900-7905
24. Dufau ML 1998 The luteinizing hormone receptor. Annu Rev Physiol 60:461-496
25. Chen CR, McLachlan SM, Rapoport B 2007 Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity. Endocrinology 148:2375-2382
26. Feng X, Muller T, Mizrachi D, Fanelli F, Segaloff DL 2008 An intracellular loop (IL2) residue confers different basal constitutive activities to the human lutropin receptor and human thyrotropin receptor through structural communication between IL2 and helix 6, via helix 3. Endocrinology 149:1705-1717
27. Corvilain B, Van SandeJ,Dumont JE, Vassart G2001 Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) 55:143-158
28. GrutersA,KrudeH,BiebermannH 2004 Molecular genetic defects in congenital hypothyroidism. Eur J Endocrinol 151(Suppl 3):U39- U44
29. Smit MJ, Vischer HF, Bakker RA, Jongejan A, Timmerman H, Pardo L, Leurs R 2007 Pharmacogenomic and structural analysis of constitutiveG protein-coupled receptor activity. Annu Rev Pharmacol Toxicol 47:53-87
30. Garcia-Jimenez C, Santisteban P 2007 TSH signalling and cancer. Arq Bras Endocrinol Metabol 51:654-671
31. Seifert R, Wenzel-Seifert K 2002 Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 366: 381-416
32. Van Durme J, Horn F, Costagliola S, Vriend G, Vassart G 2006 GRIS: glycoprotein-hormone receptor information system. Mol Endocrinol 20:2247-2255
33. Horn F, Weare J, Beukers MW, Horsch S, Bairoch A, Chen W, Edvardsen O, Campagne F, Vriend G 1998 GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res 26:275-279
34. Fan QR, Hendrickson WA 2005 Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433:269-277
35. Caltabiano G, Campillo M, De Leener A, Smits G, Vassart G, Costagliola S, Pardo L 2008 The specificity of binding of glycoprotein hormones to their receptors. Cell Mol Life Sci 65:2484-2492
36. Moyle WR, Xing Y, Lin W, Cao D, Myers RV, Kerrigan JE, Bernard MP 2004 Model of glycoprotein hormone receptor ligand binding and signaling. J Biol Chem 279:44442-44459
37. Puett D, Li Y, DeMars G, Angelova K, Fanelli F 2007 A functional transmembrane complex: the luteinizing hormone receptor with bound ligand and G protein. Mol Cell Endocrinol 260-262:126-136
38. Nurwakagari P, Breit A, Hess C, Salman-Livny H, Ben Menahem D, Gudermann T 2007 A conformational contribution of the luteinizing hormone-receptor ectodomain to receptor activation. J Mol Endocrinol 38:259-275
39. Sangkuhl K, Schulz A, Schultz G, Schoneberg T 2002 Structural requirements for mutational lutropin/choriogonadotropin receptor activation. J Biol Chem 277:47748-47755
40. Braun T, Schofield PR, Sprengel R 1991 Amino-terminal leucinerich repeats in gonadotropin receptors determine hormone selectivity. EMBO J 10:1885-1890
41. Nagayama Y, Russo D, Chazenbalk GD, Wadsworth HL, Rapoport B 1990 Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding. Biochem Biophys Res Commun 173: 1150-1156
42. Enkhbayar P, Kamiya M, Osaki M, Matsumoto T, Matsushima N 2004 Structural principles of leucine-rich repeat (LRR) proteins. Proteins 54:394-403
43. Kobe B, Deisenhofer J 1995 A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 374:183-186
44. Kajava AV 2001 Review: proteins with repeated sequence-structural prediction and modeling. J Struct Biol 134:132-144
45. KajavaAV 1998 Structural diversity of leucine-rich repeat proteins. J Mol Biol 277:519-527
46. Bella J, Hindle KL, McEwan PA, Lovell SC 2008 The leucine-rich repeat structure. Cell Mol Life Sci 65:2307-2333
47. Kobe B, Deisenhofer J 1995 Proteins with leucine-rich repeats. Curr Opin Struct Biol 5:409-416
48. Jiang X, Dreano M, Buckler DR, Cheng S, Ythier A, Wu H, Hendrickson WA, el Tayar N 1995 Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions. Structure 3:1341-1353
49. Bhowmick N, Huang J, Puett D, Isaacs NW, Lapthorn AJ 1996 Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Mol Endocrinol 10:1147-1159
50. Smits G, Campillo M, Govaerts C, Janssens V, Richter C, Vassart G, Pardo L, Costagliola S 2003 Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 22:2692-2703
51. Nunez MR, Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Blundell TL, Rees SB, Furmaniak J 2004 Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling. Thyroid 14:991-1011
52. Kobe B, Deisenhofer J 1993 Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 366: 751-756
53. Schulman BA, Carrano AC, Jeffrey PD, Bowen Z, Kinnucan ER, Finnin MS, Elledge SJ, Harper JW, Pagano M, Pavletich NP 2000 Insights into SCF ubiquitin ligases from the structure of the Skp1- Skp2 complex. Nature 408:381-386
54. Kleinau G, Jaschke H, Neumann S, Lattig J, Paschke R, Krause G 2004 Identification of a novel epitope in the thyroid-stimulating hormone receptor ectodomain acting as intramolecular signaling interface. J Biol Chem 279:51590-51600
55. He XL, Bazan JF, McDermott G, Park JB, Wang K, Tessier-Lavigne M, He Z, Garcia KC 2003 Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron 38:177-185
56. Gromoll J, Schulz A, Borta H, Gudermann T, Teerds KJ, Greschniok A, Nieschlag E, Seif FJ 2002 Homozygous mutation within the conserved Ala-Phe-Asn-Glu-Thr motif of exon 7 of the LH receptor causes male pseudohermaphroditism. Eur J Endocrinol 147:597-608
57. Puett D, Li Y, Angelova K, DeMars G, Meehan TP, Fanelli F, Narayan P 2005 Structure-function relationships of the luteinizing hormone receptor. Ann NY Acad Sci 1061:41-54
58. Fan QR, Hendrickson WA 2008 Comparative structural analysis of the binding domain of follicle stimulating hormone receptor. Proteins 72:393-401
59. Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, Bolton J, Reeve M, Nakatake N, Evans M, Richards T, Powell M, Miguel RN, Blundell TL, Furmaniak J, Smith BR 2007 Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17:395-410
60. Smith BR, Sanders J, Furmaniak J 2007 TSH receptor antibodies. Thyroid 17:923-938
61. Fan QR, Hendrickson WA 2007 Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor. Mol Cell Endocrinol 260-262:73-82
62. Dias JA 2005 Endocrinology: fertility hormone in repose. Nature 433:203-204
63. Vischer HF, Granneman JC, Koelink PJ, Marques RB, Bogerd J 2008 Identification of a luteinizing hormone-selective determinant in the exodomain of a follicle-stimulating hormone receptor. Gen Comp Endocrinol 156:490-498
64. Bogerd J 2007 Ligand-selective determinants in gonadotropin receptors. Mol Cell Endocrinol 260-262:144-152
65. Vischer HF, Granneman JC, Bogerd J 2006 Identification of folliclestimulating hormone-selective β-strands in the N-terminal hormonebinding exodomain of human gonadotropin receptors. Mol Endocrinol 20:1880-1893
66. Vischer HF, Granneman JC, Noordam MJ, Mosselman S, Bogerd J 2003 Ligand selectivity of gonadotropin receptors. Role of the β-strands of extracellular leucine-rich repeats 3 and 6 of the human luteinizing hormone receptor. J Biol Chem 278:15505-15513
67. Lin W, Bernard MP, Cao D, Myers RV, Kerrigan JE, Moyle WR 2007 Follitropin receptors contain cryptic ligand binding sites. Mol Cell Endocrinol 260-262:83-92
68. Bhowmick N, Narayan P, Puett D 1999 Identification of ionizable amino acid residues on the extracellular domain of the lutropin receptor involved in ligand binding. Endocrinology 140:4558-4563
69. Costagliola S, Urizar E, Mendive F, Vassart G 2005 Specificity and promiscuity of gonadotropin receptors. Reproduction 130:275-281
70. Kosugi S, Ban T, Akamizu T, Kohn LD 1991 Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors. Relationship of functional and immunogenic domains. J Biol Chem 266:19413-19418
71. Morris JC, Bergert ER, McCormick DJ 1993 Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides. J Biol Chem 268:10900-10905
72. Shepherd PS, Da Costa CR, Cridland JC, Gilmore KS, Johnstone AP1999 Identification of an important thyrotrophin binding site on the human thyrotrophin receptor using monoclonal antibodies. Mol Cell Endocrinol 149:197-206
73. Lin W, Bernard MP, Cao D, Myers RV, Kerrigan JE, Moyle WR 2007 Follitropin receptors contain cryptic ligand binding sites. Mol Cell Endocrinol 260-262:83-92
74. Rapoport B, McLachlan SM 2007 The thyrotropin receptor in Graves' disease. Thyroid 17:911-922
75. Szkudlinski MW 2004 Past, presence and future of thyroid-stimulating hormone (TSH) superactive analogs. Cancer Treat Res 122: 345-356
76. Mueller S, Kleinau G, Jaeschke H, Paschke R, Krause G 2008 Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation. J Biol Chem 283:18048-18055
77. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M 2000 Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289:739-745
78. Gudermann T, Nurwakagari P, Ben Menahem D 2005 Hormone binding to the follicle-stimulating hormone receptor- crystal clear! Exp Clin Endocrinol Diabetes 113:245-247
79. Hsu SY, Nakabayashi K, Bhalla A 2002 Evolution of glycoprotein hormone subunit genes in bilateral metazoa: identification of two novel human glycoprotein hormone subunit family genes, GPA2 and GPB5. Mol Endocrinol 16:1538-1551
80. Okajima Y, Nagasaki H, Suzuki C, Suga H, Ozaki N, Arima H, Hamada Y, Civelli O, Oiso Y 2008 Biochemical roles of the oligosaccharide chains in thyrostimulin, a heterodimeric hormone of glycoprotein hormone subunits α 2 (GPA2) and β 5 (GPB5). Regul Pept 148:62-67
81. Sudo S, Kuwabara Y, Park JI, Hsu SY, Hsueh AJ 2005 Heterodimeric fly glycoprotein hormone-α2 (GPA2) and glycoprotein hormone-β5 (GPB5) activate fly leucine-rich repeat-containing G protein-coupled receptor-1 (DLGR1) and stimulation of human thyrotropin receptors by chimeric fly GPA2 and human GPB5. Endocrinology 146:3596-3604
82. Okada SL, Ellsworth JL, Durnam DM, Haugen HS, Holloway JL, Kelley ML, Lewis KE, Ren H, Sheppard PO, Storey HM, Waggie KS, Wolf AC, Yao LY, Webster PJ 2006 A glycoprotein hormone expressed in corticotrophs exhibits unique binding properties on thyroid-stimulating hormone receptor. Mol Endocrinol 20:414-425
83. Lantz M, Vondrichova T, Capretz A, Nilsson E, Frenander C, Bondeson AG, Ridderstrale M, Aberg M, Asman P, Groop L, Hallengren B 2007 Thyrostimulin (a TSH-like hormone) expression in orbital and thyroid tissue. Thyroid 17:113-118
84. Bruysters M, Verhoef-Post M, Themmen AP 2008 Asp330 and Tyr331 in the C terminal cysteine rich region of the luteinizing hormone receptor are key residues in hormone-induced receptor activation. J Biol Chem 283:25821-25828
85. Chen CR, Tanaka K, Chazenbalk GD, McLachlan SM, Rapoport B 2001 A full biological response to autoantibodies in Graves' disease requires a disulfide-bonded loop in the thyrotropin receptor N terminus homologous to a laminin epidermal growth factorlike domain. J Biol Chem 276:14767-14772
86. Hsu SY, Liang SG, Hsueh AJ 1998 Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seventransmembrane region. Mol Endocrinol 12:1830-1845
87. Kudo M, Chen T, Nakabayashi K, Hsu SY, Hsueh AJ 2000 The nematode leucine-rich repeat-containing, G protein-coupled receptor (LGR) protein homologous to vertebrate gonadotropin and thyrotropin receptors is constitutively active in mammalian cells. Mol Endocrinol 14:272-284
88. Hsu SY, KudoM,ChenT,NakabayashiK,BhallaA,van der Spek PJ, van Duin M, Hsueh AJ 2000 The three subfamilies of leucinerich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol 14:1257-1271
89. Nishi S, Hsu SY, Zell K, Hsueh AJ 2000 Characterization of two fly LGR (leucine-rich repeat-containing, G protein-coupled receptor) proteins homologous to vertebrate glycoprotein hormone receptors: constitutive activation of wild-type fly LGR1 but not LGR2 in transfected mammalian cells. Endocrinology 141:4081-4090
90. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD,HsuehAJ 2002 Activationof orphan receptorsbythe hormone relaxin. Science 295:671-674
91. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RA, Hsueh AJ 2003 H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem 278:7855-7862
92. Van Loy T, Vandersmissen HP, Van Hiel MB, Poels J, Verlinden H, Badisco L, Vassart G, Vanden Broeck J 2008 Comparative genomics of leucine-rich repeats containing G protein-coupled receptors and their ligands. Gen Comp Endocrinol 155:14-21
93. De Leener A, Caltabiano G, Erkan S, Idil M, Vassart G, Pardo L, Costagliola S 2008 Identification of the first germline mutation in the extracellular domain of the follitropin receptor responsible for spontaneous ovarian hyperstimulation syndrome. Hum Mutat 29: 91-98
94. Rodien P, Bremont C, Sanson ML, Parma J, Van Sande J, Costagliola S, Luton JP, Vassart G, Duprez L 1998 Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 339:1823-1826
95. Nagayama Y, Rapoport B 1992 Role of the carboxyl-terminal half of the extracellular domain of the human thyrotropin receptor in signal transduction. Endocrinology 131:548-552
96. Bernard MP, Myers RV, Moyle WR 1998 Lutropins appear to contact two independent sites in the extracellular domain of their receptors. Biochem J 335:611-617
97. Nagayama Y, Wadsworth HL, Chazenbalk GD, Russo D, Seto P, Rapoport B 1991 Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function. Proc Natl Acad Sci USA 88:902-905
98. Costagliola S, Panneels V, Bonomi M, Koch J, Many MC, Smits G, Vassart G 2002 Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J 21:504-513
99. Mizutori Y, Chen CR, McLachlan SM, Rapoport B 2008 The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction. Mol Endocrinol 22:1171-1182
100. Bonomi M, Busnelli M, Persani L, Vassart G, Costagliola S 2006 Structural differences in the hinge region of the glycoprotein hormone receptors: evidence from the sulfated tyrosine residues. Mol Endocrinol 20:3351-3363
101. Kleinau G, Jaeschke H, Mueller S, Raaka BM, Neumann S, Paschke R, Krause G 2008 Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor. FASEB J 22:2798-2808
102. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S 2002 Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16:736-746
103. Karges B, Gidenne S, Aumas C, Haddad F, Kelly PA, Milgrom E, de Roux N 2005 Zero-length cross-linking reveals that tight interactions between the extracellular and transmembrane domains of the luteinizing hormone receptor persist during receptor activation. Mol Endocrinol 19:2086-2098
104. Neumann S, Claus M, Paschke R 2005 Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation. Eur J Endocrinol 152:625-634
105. Zeng H, Phang T, Song YS, Ji I, Ji TH 2001 The role of the hinge region of the luteinizing hormone receptor in hormone interaction and signal generation. J Biol Chem 276:3451-3458
106. Zhang M, Tong KP, Fremont V, Chen J, Narayan P, Puett D, Weintraub BD, Szkudlinski MW 2000 The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinology 141:3514-3517
107. Mueller S, Kleinau G, Jaeschke H, Neumann S, Krause G, Paschke R 2006 Significance of ectodomain cysteine boxes 2 and 3 for the activation mechanism of the thyroid-stimulating hormone receptor. J Biol Chem 281:31638-31646
108. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716
109. Couet J, Sar S, Jolivet A, Hai MT, Milgrom E, Misrahi M 1996 Sheddingofhuman thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease. J Biol Chem 271:4545-4552
110. de Bernard S, Misrahi M, Huet JC, Beau I, Desroches A, Loosfelt H, PichonC,Pernollet JC, MilgromE1999 Sequential cleavage and excision of a segment of the thyrotropin receptor ectodomain. J Biol Chem 274:101-107
111. Bozon V, Couture L, Pajot-Augy E, Richard F, Remy JJ, Salesse R 2002 Rescue of intracellularly trapped lutropin receptor exodomain by endodomain and reconstitution of a functional membrane receptor: interaction between exo- and endodomains. Protein Expr Purif 25:114-123
112. Zhang R, Buczko E, Dufau ML 1996 Requirement of cysteine residues in exons 1-6 of the extracellular domain of the luteinizing hormone receptor for gonadotropin binding. J Biol Chem 271:5755-5760
113. HoSC, Goh SS,SuQ,KhooDH 2005 Cysteine 390 mutation of the TSH receptor modulates its ectodomain asan inverse agonist on the serpentine domain with decrease in basal constitutive activity. Mol Cell Endocrinol 245:158-168
114. Ho SC, Goh SS, Li S, Khoo DH, Paterson M 2008 Effects of mutations involving cysteine residues distal to the S281HCC motif at the C-terminus on the functional characteristics of a truncated ectodomain-only thyrotropin receptor anchored on glycosylphosphatidyl-inositol. Thyroid 18:1313-1319
115. Duprez L, Parma J, Costagliola S, Hermans J, Van Sande J, Dumont JE, Vassart G 1997 Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 409:469-474
116. Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL, Rodd C 1997 Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281→isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 100:1634-1639
117. Ho SC, Van Sande J, Lefort A, Vassart G, Costagliola S 2001 Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology 142:2760-2767
118. Jaeschke H, Neumann S, Kleinau G, Mueller S, Claus M, Krause G, Paschke R 2006 An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function. Endocrinology 147:1753-1760
119. Nakabayashi K, Kudo M, Kobilka B, Hsueh AJ 2000 Activation of the luteinizing hormone receptor following substitution of Ser- 277 with selective hydrophobic residues in the ectodomain hinge region. J Biol Chem 275:30264-30271
120. Nakabayashi K, Kudo M, Hsueh AJ, Maruo T 2003 Activation of the luteinizing hormone receptor in the extracellular domain. Mol Cell Endocrinol 202:139-144
121. Chazenbalk GD, TanakaK,NagayamaY,KakinumaA,Jaume JC, McLachlan SM, Rapoport B 1997 Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites. Endocrinology 138:2893-2899
122. Misrahi M, Milgrom E 1997 Cleavage and shedding of the TSH receptor. Eur J Endocrinol 137:599-602
123. Tanaka K, Chazenbalk GD, McLachlan SM, Rapoport B 1998 Thyrotropin receptor cleavage at site 1 does not involve a specific amino acid motif but instead depends on the presence of the unique, 50 amino acid insertion. J Biol Chem 273:1959-1963
124. Chazenbalk GD, McLachlan SM, Chen CR, Rapoport B 2001 Insight into thyrotropin receptor cleavage by engineering the single polypeptide chain luteinizing hormone receptor into a cleaving, two subunit receptor. Eur J Biochem 268:2261-2269
125. Quellari M, Desroches A, Beau I, Beaudeux E, Misrahi M 2003 Role of cleavage and shedding in human thyrotropin receptor function and trafficking. Eur J Biochem 270:3486-3497
126. Latif R, Ando T, Davies TF 2004 Monomerization as a prerequisite for intramolecular cleavage and shedding of the thyrotropin receptor. Endocrinology 145:5580-5588
127. Vassart G, Costagliola S 2004 A physiological role for the posttranslational cleavage of the thyrotropin receptor? Endocrinology 145:1-3
128. Kaczur V, Puskas LG, Nagy ZU, Miled N, Rebai A, Juhasz F, Kupihar Z, Zvara A, Hackler Jr L, Farid NR 2007 Cleavage of the human thyrotropin receptor by ADAM10 is regulated by thyrotropin. J Mol Recognit 20:392-404
129. Hai MT, Radu A, Ghinea N 4 Jul 2008 The cleavage of thyroidstimulating hormone receptor is dependent on cell-cell contacts and regulates the hormonal stimulation of phospholipase C. J Cell Mol Med 10.1111/j.1582-4934.2008.00422.x
130. Chen CR, Chazenbalk GD, Wawrowsky KA, McLachlan SM, Rapoport B 2006 Evidence that human thyroid cells express uncleaved, single-chain thyrotropin receptors on their surface. Endocrinology 147:3107-3113
131. Claus M, Jaeschke H, Kleinau G, Neumann S, Krause G, Paschke R 2005 A hydrophobic cluster in the center of the third extracellular loop is important for thyrotropin receptor signaling. Endocrinology 146:5197-5203
132. Stavrou SS, Zhu YS, Cai LQ, Katz MD, Herrera C, Defillo-Ricart M, Imperato-McGinley J 1998 A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 83:2091-2098
133. Huang J, Puett D 1995 Identification of two amino acid residues on the extracellular domain of the lutropin/choriogonadotropin receptor important in signaling. J Biol Chem 270:30023-30028
134. de Roux N, Misrahi M, Brauner R, Houang M, Carel JC, Granier M, Le Bouc Y, Ghinea N, Boumedienne A, Toublanc JE, Milgrom E 1996 Four families with loss of function mutations of the thyrotropin receptor. J Clin Endocrinol Metab 81:4229-4235
135. Muller T, Gromoll J, Simoni M 2003 Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action. J Clin Endocrinol Metab 88:2242-2249
136. Muller T, Gromoll J, Simula AP, Norman R, Sandhowe- Klaverkamp R, Simoni M 2004 The carboxyterminal peptide of chorionic gonadotropin facilitates activation of the marmoset LH receptor. Exp Clin Endocrinol Diabetes 112:574-579
137. Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J 1996 Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 81:547-554
138. Grasberger H, Van Sande J, Hag-Dahood MA, Tenenbaum- Rakover Y, Refetoff S 2007 A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/ Ca2 + cascade mediates TSH action on thyroid hormone synthesis. J Clin Endocrinol Metab 92:2816-2820
139. Fuhrer D, Holzapfel HP, Wonerow P, Scherbaum WA, Paschke R 1997 Somatic mutations in the thyrotropin receptor gene and not in the Gs α protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885-3891
140. Akcurin S, Turkkahraman D, Tysoe C, Ellard S, De Leener A, Vassart G, Costagliola S 2008 A family with a novel TSH receptor activating germline mutation (p.Ala485Val). Eur J Pediatr 167: 1231-1237
141. Camilot M, Teofoli F, Gandini A, Franceschi R, Rapa A, Corrias A, Bona G, Radetti G, Tato L 2005 Thyrotropin receptor gene mutations and TSH resistance: variable expressivity in the heterozygotes. Clin Endocrinol (Oxf) 63:146-151
142. Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J, Vassart G 1995 Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2 + cascades. Mol Endocrinol 9:725-733
143. Claus M, Maier J, Paschke R, Kujat C, Stumvoll M, Fuhrer D 2005 Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism. Thyroid 15:1089-1094
144. Gozu HI, Bircan R, Krohn K, Muller S, Vural S, Gezen C, Sargin H, Yavuzer D, Sargin M, Cirakoglu B, Paschke R 2006 Similar prevalence of somatic TSH receptor and Gsα mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol 155:535-545
145. Holzapfel HP, Fuhrer D, Wonerow P, Weinland G, Scherbaum WA, Paschke R 1997 Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. J Clin Endocrinol Metab 82:4229-4233
146. Ryu K, Lee H, Kim S, Beauchamp J, Tung CS, Isaacs NW, Ji I, Ji TH 1998 Modulation of high affinity hormone binding. Human choriogonadotropin binding to the exodomain of the receptor is influenced by exoloop 2 of the receptor. J Biol Chem 273:6285-6291
147. Li S, Liu X, Min L, Ascoli M 2001 Mutations of the second extracellular loop of the human lutropin receptor emphasize the importance of receptor activation and de-emphasize the importance of receptor phosphorylation in agonist-induced internalization. J Biol Chem 276:7968-7973
148. Gilchrist RL, Ryu KS, Ji I, Ji TH 1996 The luteinizing hormone/ chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals. J Biol Chem 271:19283-19287
149. Ryu K, Gilchrist RL, Tung CS, Ji I, Ji TH 1998 High affinity hormone binding to the extracellular N-terminal exodomain of the follicle-stimulating hormone receptor is critically modulated by exoloop 3. J Biol Chem 273:28953-28958
150. Sohn J, Ryu K, Sievert G, Jeoung M, Ji I, Ji TH 2002 Folliclestimulating hormone interacts with exoloop 3 of the receptor. J Biol Chem 277:50165-50175
151. Fernandez LM, Puett D 1996 Lys583 in the third extracellular loop of the lutropin/choriogonadotropin receptor is critical for signaling. J Biol Chem 271:925-930
152. Kleinau G, Claus M, Jaeschke H, Mueller S, Neumann S, Paschke R, Krause G 2007 Contacts between extracellular loop two and transmembrane helix six determine basal activity of the thyroidstimulating hormone receptor. J Biol Chem 282:518-525
153. Ji I, Ji TH 1995 Differential roles of exoloop 1 of the human folliclestimulating hormone receptor in hormone binding and receptor activation. J Biol Chem 270:15970-15973
154. Camacho P, Gordon D, Chiefari E, Yong S, DeJong S, Pitale S, Russo D, Filetti S 2000 A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism. Thyroid 10:1009-1012
155. Herold CL, Qi AD, Harden TK, Nicholas RA 2004 Agonist versus antagonist action of ATP at the P2Y4 receptor is determined by the second extracellular loop. J Biol Chem 279:11456-11464
156. Seong JY, Wang L, Oh DY, Yun O, Maiti K, Li JH, Soh JM, Choi HS, Kim K, Vaudry H, Kwon HB 2003 Ala/Thr(201) in extracellular loop 2 and Leu/Phe(290) in transmembrane domain 6 of type 1 frog gonadotropin-releasing hormone receptor confer differential ligand sensitivity and signal transduction. Endocrinology 144:454-466
157. Zoffmann S, Chollet A, Galzi JL 2002 Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1α and its CCR1 receptor. Mol Pharmacol 62:729-736
158. Massotte D, Kieffer BL 2005 The second extracellular loop: a damper for G protein-coupled receptors? Nat Struct Mol Biol 12: 287-288
159. Couture L, Remy JJ, Rabesona H, Troalen F, Pajot-Augy E, Bozon V, Haertle T, Bidart JM, Salesse R 1996 A defined epitope on the human choriogonadotropin α-subunit interacts with the second extracellular loop of the transmembrane domain of the lutropin/ choriogonadotropin receptor. Eur J Biochem 241:627-632
160. Kleinau G, Jaeschke H, Mueller S, Worth CL, Paschke R, Krause G 2008 Molecular and structural effects of inverse agonistic mutations on signaling of the thyrotropin receptor-a basally active GPCR. Cell Mol Life Sci 65:3664-3676
161. Teller DC, Okada T, Behnke CA, Palczewski K, Stenkamp RE 2001 Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40:7761-7772
162. Okada T, Sugihara M, Bondar AN, Elstner M, Entel P, Buss V 2004 The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol 342:571-583
163. Li J, Edwards PC, Burghammer M, Villa C, Schertler GF 2004 Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol 343:1409-1438
164. Salom D, Lodowski DT, Stenkamp RE, Le Trong I, Golczak M, Jastrzebska B, Harris T, Ballesteros JA, Palczewski K 2006 Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc Natl Acad Sci USA 103:16123-16128
165. Standfuss J, Xie G, Edwards PC, Burghammer M, Oprian DD, Schertler GF 2007 Crystal structure of a thermally stable rhodopsin mutant. J Mol Biol 372:1179-1188
166. Park JH, Scheerer P, Hofmann KP, Choe HW, Ernst OP 2008 Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454:183-187
167. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC 2007 High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318: 1258-1265
168. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, Kobilka BK 2007 Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450: 383-387
169. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler GF 2008 Structure of a β1-adrenergic G-protein-coupled receptor. Nature 454:486-491
170. Costanzi S,Mamedova L, Gao ZG,Jacobson KA 2004Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem 47:5393-5404
171. Liu S, Fan S, Sun Z 2003 Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies. J Mol Model 9:329-336
172. Deflorian F, Engel S, Colson AO, Raaka BM, Gershengorn MC, Costanzi S 2008 Understanding the structural and functional differences between mouse thyrotropin-releasing hormone receptors 1 and 2. Proteins 71:783-794
173. Ballesteros JA, Weinstein H 1995 Integrated methods for the construction of three-dimensional models and computational probing of structure-function relationships in G-protein coupled receptors. Methods Neurosci 25:366-428
174. Lawson Z, Wheatley M 2004 The third extracellular loop of G- protein-coupled receptors: more than just a linker between two important transmembrane helices. Biochem Soc Trans 32:1048-1050
175. Wonerow P, Chey S, Fuhrer D, Holzapfel HP, Paschke R 2000 Functional characterization of five constitutively activating thyrotrophin receptor mutations. Clin Endocrinol (Oxf) 53:461-468
176. Ryu KS, Gilchrist RL, Ji I, Kim SJ, Ji TH 1996 Exoloop 3 of the luteinizing hormone/choriogonadotropin receptor. Lys583 is essential and irreplaceable for human choriogonadotropin (hCG)- dependent receptor activation but not for high affinity hCG binding. J Biol Chem 271:7301-7304
177. Vassart G, Pardo L, Costagliola S 2004 A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 29:119-126
178. Gromoll J, Eiholzer U, Nieschlag E, Simoni M 2000 Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 85:2281-2286
179. Leitolf H, Tong KP, Grossmann M, Weintraub BD, Szkudlinski MW 2000 Bioengineering of human thyrotropin superactive analogs by site-directed "lysine-scanning" mutagenesis. Cooperative effects between peripheral loops. J Biol Chem 275:27457-27465
180. Jaeschke H, Kleinau G, Sontheimer J, Mueller S, Krause G, Paschke R 2008 Preferences of transmembrane helices for cooperative amplification of G(α)s and G (α)q signaling of the thyrotropin receptor. Cell Mol Life Sci 65:4028-4038
181. Neumann S, Kleinau G, Costanzi S, Moore S, Jiang JK, Raaka BM, Thomas CJ, Krause G, Gershengorn MC 2008 A low molecular weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. Endocrinology 149:5945-5950
182. Heitman LH, Ijzerman AP 2008 G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for GnRH, LH, FSH, and GPR54 receptor ligands. Med Res Rev 28:975-1011
183. Van Sande J, Costa MJ, Massart C, Swillens S, Costagliola S, Orgiazzi J, Dumont JE 2003 Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cells. J Clin Endocrinol Metab 88:5366-5374
184. Schmidt A, MacColl R, Lindau-Shepard B, Buckler DR, Dias JA 2001 Hormone-induced conformational change of the purified soluble hormone binding domain of follitropin receptor complexed with single chain follitropin. J Biol Chem 276:23373-23381
185. Jaquette J, Segaloff DL 2002 Constitutive activation of the LH receptor is associated with an alteration in the conformation of the ectodomain. Mol Cell Endocrinol 194:211-215
186. Urizar E, Montanelli L, Loy T, Bonomi M, Swillens S, Gales C, Bouvier M, Smits G, Vassart G, Costagliola S 2005 Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J 24:1954-1964
187. Latif R, Graves P, Davies TF 2001 Oligomerization of the human thyrotropin receptor: fluorescent protein-tagged hTSHR reveals post-translational complexes. J Biol Chem 276:45217-45224
188. Graves PN, Vlase H, Davies TF 1995 Folding of the recombinant human thyrotropin (TSH) receptor extracellular domain: identification of folded monomeric and tetrameric complexes that bind TSH receptor autoantibodies. Endocrinology 136:521-527
189. Graves PN, Vlase H, Bobovnikova Y, Davies TF 1996 Multimeric complex formation by the thyrotropin receptor in solubilized thyroid membranes. Endocrinology 137:3915-3920
190. Persani L, Calebiro D, Bonomi M 2007 Technology insight: modern methods to monitor protein-protein interactions reveal functional TSH receptor oligomerization. Nat Clin Pract Endocrinol Metab 3:180-190
191. Osuga Y, Hayashi M, Kudo M, Conti M, Kobilka B, Hsueh AJ 1997 Co-expression of defective luteinizing hormone receptor fragments partially reconstitutes ligand-induced signal generation. J Biol Chem 272:25006-25012
192. Jeoung M, Lee C, Ji I, Ji TH 2007 Trans-activation, cis-activation and signal selection of gonadotropin receptors. Mol Cell Endocrinol 260-262:137-143
193. Svendsen AM, VreclM,Ellis TM, HedingA,Kristensen JB, Wade JD, Bathgate RA, De Meyts P, Nohr J 2008 Cooperative binding of insulin-like peptide 3to a dimeric relaxin family peptide receptor 2. Endocrinology 149:1113-1120
194. Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, Choe HW, Hofmann KP, Ernst OP 2008 Crystal structure of opsin in its G-protein-interacting conformation. Nature 455:497-502
195. Claus M, Neumann S, Kleinau G, Krause G, Paschke R 2006 Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor. J Mol Med 84:943-954
196. Fanelli F, Dell'Orco D 2005 Rhodopsin activation follows precoupling with transducin: inferences from computational analysis. Biochemistry 44:14695-14700
197. Filipek S, Krzysko KA, Fotiadis D,Liang Y, Saperstein DA, Engel A, Palczewski K 2004 A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface. Photochem Photobiol Sci 3:628-638